Alemtuzumab-based reduced-intensity conditioning for XIAP deficiency

被引：1
|
作者：
Kobushi, Hirokazu [1 ]
Umeda, Katsutsugu [1 ,4 ]
Hiejima, Eitaro [1 ]
Kato, Kentaro [1 ]
Sugimoto, Mayumi [2 ]
Kanegane, Hirokazu [3 ]
Takita, Junko [1 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan
[2] Tokushima Univ, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan
[3] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Child Hlth & Dept, Tokyo, Japan
[4] Kyoto Univ, Grad Sch Med, Dept Pediat, 54 Kawahara Cho, Shogoin, Sakyo ku, Kyoto 6068507, Japan
来源：
PEDIATRICS INTERNATIONAL | 2023年 / 65卷 / 01期
关键词：
alemtuzumab; allogenic hematopoietic cell transplantation; mixed chimerism; XIAP deficiency; HEMATOPOIETIC-CELL TRANSPLANTATION;
D O I：
10.1111/ped.15576
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Successful treatment of idiopathic colitis related to XIAP deficiency with allo-HSCT using reduced-intensity conditioning
    Tsuma, Yusuke
    Imamura, Toshihiko
    Ichise, Eisuke
    Sakamoto, Kenichi
    Ouchi, Kazutaka
    Osone, Shinya
    Ishida, Hiroyuki
    Wada, Taizo
    Hosoi, Hajime
    PEDIATRIC TRANSPLANTATION, 2015, 19 (01) : E25 - E28
  • [22] Alemtuzumab and reduced intensity conditioning
    Mackinnon, S
    BLOOD, 2002, 100 (04) : 1508 - 1509
  • [23] Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes
    Lim, Zi Yi
    Ho, Aloysius Y. L.
    Ingram, Wendy
    Kenyon, Michelle
    Pearce, Laurence
    Czepulkowski, Barbara
    Devereux, Stephen
    Duarte, Rafael F.
    Pagliuca, Antonio
    Mufti, Ghulam J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (02) : 201 - 209
  • [24] Long term outcomes of adults undergoing alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation
    Ceesay, M. Mansour
    Lim, ZiYi
    Kenyon, Michelle
    Ho, Aloysius Y. L.
    Devereux, Stephen
    Schey, Steve
    Mijovic, Aleksandar
    Pagliuca, Antonio
    Mufti, Ghulam J.
    BLOOD, 2007, 110 (11) : 496A - 497A
  • [25] Long term outcomes of adults undergoing alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation
    Ceesa, M. M.
    Lim, Z. Y.
    Kenyon, M.
    Ho, A.
    Devereux, S.
    Schey, S.
    Mijovic, A.
    Pagliuca, A.
    Mufti, G. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 53 - 54
  • [26] Reduced-intensity conditioning with busulfan, fludarabine and alemtuzumab in children and adolescents: a pilot study
    Styczynski, J.
    Tallamy, B.
    Fearon, N.
    De Ven, C. Van
    Harrison, L.
    Morris, E.
    Satwani, P.
    Bhatia, M.
    George, D.
    Bradley, B.
    Garvin, J.
    Schwartz, J.
    Baxter-Lowe, L.
    Cairo, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S294 - S294
  • [27] Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study
    Delgado, J
    Thomson, K
    Russell, N
    Ewing, J
    Stewart, W
    Cook, G
    Devereux, S
    Lovell, R
    Chopra, R
    Marks, DI
    Mackinnon, S
    Milligan, DW
    BLOOD, 2006, 107 (04) : 1724 - 1730
  • [28] Incidence and outcome of Adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab
    Avivi, I
    Chakrabarti, S
    Milligan, DW
    Waldmann, H
    Hale, G
    Osman, H
    Ward, KN
    Fegan, CD
    Yong, K
    Goldstone, AH
    Limb, DC
    MacKinnon, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (03) : 186 - 194
  • [29] Reduced-intensity conditioning preferred for AML
    Nature Reviews Clinical Oncology, 2012, 9 (11) : 611 - 611
  • [30] HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced intensity conditioning
    Mead, A.
    Thomson, K. J.
    Morris, E. C.
    Mohamedbhai, S.
    Orti, G.
    Chakraverty, R.
    Linch, D. C.
    Mackinnon, S.
    Peggs, K. S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 21 - 21
12345